What type of study is this?

This is a Observational study (also classified as: In Vitro Study).

August 20, 2025Open Access

The EBV-Positive Tumor Methylome is Distinct from EBV-Negative in Diffuse Large B-Cell Lymphoma

View Full Paper

Ask AI

Bookmark

EBV(+) DLBCL exhibits a distinct, hypermethylated DNA methylome compared to EBV(-) cases, indicating significant epigenetic differences.
Analysis identified over 117,000 differential methylation probes in EBV(+) DLBCL linked to 1,557 cancer-associated genes, showing substantial biological implications.
Using global DNA methylation profiling with the MethylationEPIC array, the study employed linear mixed models for differential analyses across a curated cohort.
The findings suggest potential biomarkers for disease classification and highlight clinical heterogeneity in DLBCL—further studies may explore therapeutic targeting.

No takes yet. Share an insight, caveat, or question.

Global methylome analysis reveals unique epigenetic signatures in EBV(+) DLBCL, suggesting biomarkers for classification.

Volaric et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark